| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Samuel A Shelburne | |
| Richard J Hamill | |||
| Martin Montes | |||
| P2860 | cites work | HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells | Q24802813 |
| Immunorestitution disease involving the innate and adaptive response | Q33958197 | ||
| Decline in the AIDS and death rates in the EuroSIDA study: an observational study | Q33967061 | ||
| Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy | Q34024859 | ||
| Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy | Q34629205 | ||
| Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients | Q35014100 | ||
| A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. | Q36078042 | ||
| Depletion of regulatory T cells in HIV infection is associated with immune activation | Q38881101 | ||
| Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy | Q38920844 | ||
| The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy. | Q39105470 | ||
| Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. | Q40642481 | ||
| MHC haplotypes affect the expression of opportunistic infections in HIV patients | Q40826866 | ||
| Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy. | Q43974368 | ||
| Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease | Q45500943 | ||
| The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy | Q46433636 | ||
| Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. | Q47876081 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| immune reconstitution inflammatory syndrome | Q539986 | ||
| P304 | page(s) | 167-170 | |
| P577 | publication date | 2005-12-14 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Immune reconstitution inflammatory syndrome: more answers, more questions | |
| P478 | volume | 57 |
| Q33756118 | A non-synonymous polymorphism in IL-23R Gene (rs1884444) is associated with reduced risk to schistosomiasis-associated Immune Reconstitution Inflammatory Syndrome in a Kenyan population |
| Q59353840 | AIDS Cholangiopathy Secondary to Cytomegalovirus as Possible Unmasking Immune Reconstitution Inflammatory Syndrome in Human Immunodeficiency Virus-Infected Individual: Case Report and Review of the Literature |
| Q36584311 | Acute kidney injury and inflammatory immune reconstitution syndrome in mixed genotype (A/E) hepatitis B virus co-infection in HIV-associated lymphoma |
| Q37415603 | Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges |
| Q40040109 | An HIV-positive Case of Obstructive Jaundice Caused by Immune Reconstitution Inflammatory Syndrome of Tuberculous Lymphadenitis Successfully Treated with Corticosteroids. |
| Q37848593 | An official ATS workshop report: Emerging issues and current controversies in HIV-associated pulmonary diseases |
| Q36979598 | An unusual case of paradoxical enlargement of lymph nodes during treatment of tuberculous lymphadenitis in immunocompetent patient and literature review |
| Q37364438 | Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs |
| Q37460441 | Association between Taenia solium infection and HIV/AIDS in northern Tanzania: a matched cross sectional-study |
| Q38025878 | CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 1: overview and discussion of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome and cryptococcal-immune reconstitution inflamm |
| Q27011721 | CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 2: discussion of neuro-immune reconstitution inflammatory syndrome with and without other pathogens |
| Q50137537 | Change over time of mortality predictors after HAART initiation in a Senegalese cohort |
| Q55096336 | Chylous ascites as a complication of intraabdominal Mycobacterium avium complex immune reconstitution inflammatory syndrome. |
| Q28474814 | Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses |
| Q39767247 | Clinical markers of immunodeficiency and mechanism of immune reconstitution inflammatory syndrome and highly active antiretroviral therapy on HIV: workshop 3A. |
| Q28069032 | Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis |
| Q37034498 | Cytomegalovirus-associated chorioretinitis after liver transplantation: case report and review of the literature |
| Q39436622 | Development of visceral leishmaniasis in an HIV(+) patient upon immune reconstitution following the initiation of antiretroviral therapy |
| Q37693285 | Disease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era. |
| Q34100670 | Disseminated Rhodococcus equi infection in HIV infection despite highly active antiretroviral therapy |
| Q41880357 | Does CD4+CD25+foxp3+ cell (Treg) and IL-10 profile determine susceptibility to immune reconstitution inflammatory syndrome (IRIS) in HIV disease? |
| Q37189075 | Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial |
| Q38426164 | Early initiation of antiretroviral therapy and universal HIV testing in sub-Saharan Africa: has WHO offered a milestone for HIV prevention? |
| Q38862471 | Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial |
| Q37196727 | Fatal immune reconstitution inflammatory syndrome with human immunodeficiency virus infection and Candida meningitis: case report and review of the literature. |
| Q30052157 | HIV and Tuberculosis: a Deadly Human Syndemic |
| Q35195370 | HIV protease inhibitors alter innate immune response signaling to double-stranded RNA in oral epithelial cells: implications for immune reconstitution inflammatory syndrome? |
| Q36654015 | HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome |
| Q91633293 | HIV-Associated Histoplasmosis: Current Perspectives |
| Q37245925 | HIV-Related Lung Disorders |
| Q42701998 | Human Polyomavirus-Associated Cerebral Disorders in the Post-HAART Era |
| Q90453481 | Hypersensitivity pneumonia and HIV infection in occupational settings: a case report from northern Italy |
| Q92857228 | Immune Reconstitution Inflammatory Syndrome Secondary to Autoimmune Hemolytic Anemia and Cryptococcal Meningitis |
| Q30396503 | Immune Reconstitution Inflammatory Syndrome and Tropical Dermatoses |
| Q38618442 | Immune Reconstitution Inflammatory Syndrome in HIV-Infected Immigrants. |
| Q40040664 | Immune Reconstitution Inflammatory Syndrome in Patients with AIDS and Disseminated Coccidioidomycosis: A Case Series and Review of the Literature |
| Q36514050 | Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy |
| Q46557940 | Immune reconstitution inflammatory syndrome (IRIS) of the small bowel in an immunocompromised patient suffering from systemic lupus erythematosus and non-tuberculous mycobacteriosis |
| Q33605245 | Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy |
| Q39065992 | Immune reconstitution inflammatory syndrome associated with pulmonary pathogens |
| Q40091203 | Immune reconstitution inflammatory syndrome associated with secondary syphilis |
| Q37058004 | Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management |
| Q41391515 | Immune reconstitution inflammatory syndrome in HIV-infected patients with and without prior tuberculosis |
| Q40230527 | Immune reconstitution inflammatory syndrome in a HIV-infected patient with disseminated tuberculosis |
| Q37405766 | Immune reconstitution inflammatory syndrome in a resource-poor setting |
| Q35066393 | Immune reconstitution inflammatory syndrome in a unique clinical scenario |
| Q42975888 | Immune reconstitution inflammatory syndrome in association with HIV/AIDS and tuberculosis: views over hidden possibilities |
| Q36445405 | Immune reconstitution inflammatory syndrome in human immunodeficiency virus-infected children in Peru |
| Q31164668 | Immune reconstitution inflammatory syndrome of the brain: case illustrations of a challenging entity |
| Q37028699 | Immune reconstitution is not a prognostic factor in progressive multifocal leukoencephalopathy |
| Q37172390 | Immune reconstitution reactions in human immunodeficiency virus-negative patients: report of a case and review of the literature |
| Q43744213 | Immune reconstitution to parvovirus B19 and resolution of anemia in a patient treated with highly active antiretroviral therapy |
| Q37386982 | Immune recovery uveitis associated with highly active antiretroviral therapy in a patient with CMV retinitis and AIDS despite a low CD4+ T cell count: case report and a review of the literature |
| Q34499007 | Immune restoration disease and changes in CD4+ T-cell count in HIV- infected patients during highly active antiretroviral therapy at Zewditu memorial hospital, Addis Ababa, Ethiopia |
| Q38108963 | Impact of antiretroviral therapy on lung immunology and inflammation |
| Q45377474 | JC virus infection of the brain |
| Q41885776 | Late onset CNS immune reconstitution inflammatory syndrome in an immunocompetent patient |
| Q42228714 | Molluscum contagiosum as a skin manifestation of immune reconstitution inflammatory syndrome in an AIDS patient who is receiving HAART. |
| Q36547128 | NeuroAIDS in Africa |
| Q37779049 | Neurologic consequences of the immune reconstitution inflammatory syndrome (IRIS). |
| Q37827727 | Neurologic cytomegalovirus complications in patients with AIDS: retrospective review of 13 cases and review of the literature |
| Q47586850 | Neurological opportunistic infections and neurological immune reconstitution syndrome: impact of one decade of highly active antiretroviral treatment in a tertiary hospital |
| Q37331456 | Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance |
| Q95806936 | Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries |
| Q83890740 | Oral Kaposi sarcoma: a case of immune reconstitution inflammatory syndrome |
| Q35103988 | Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report |
| Q28279296 | Pathology in euthermic bats with white nose syndrome suggests a natural manifestation of immune reconstitution inflammatory syndrome |
| Q39674196 | Post-Kala-Azar Dermal Leishmaniasis: A Paradigm of Paradoxical Immune Reconstitution Syndrome in Non-HIV/AIDS Patients |
| Q63503796 | Pulsed steroids followed by glatiramer acetate to prevent inflammatory activity after cessation of natalizumab therapy: a prospective, 6-month observational study |
| Q35715390 | Recent developments in the epidemiology and management of tuberculosis - new solutions to old problems? |
| Q38979246 | Recurrent giant molluscum contagiosum immune reconstitution inflammatory syndrome (IRIS) after initiation of antiretroviral therapy in an HIV-infected man. |
| Q42257419 | Recurrent immune reconstitution inflammatory syndrome of tuberculous brain infection in people living with HIV/AIDS: a case report |
| Q37550813 | Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia |
| Q28475281 | Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials study |
| Q33157255 | Risk factors for mortality from primary cryptococcosis in patients with HIV. |
| Q35876986 | Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome |
| Q57226316 | Spontaneous Splenic Rupture as Manifestation of the Immune Reconstitution Inflammatory Syndrome in an HIV Type 1 Infected Patient with Tuberculosis |
| Q36501447 | The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial |
| Q42283296 | The immune reconstitution inflammatory syndrome: a clinical update |
| Q33750884 | The increasing prevalence of HIV/Helicobacter pylori co-infection over time, along with the evolution of antiretroviral therapy (ART) |
| Q38102657 | The long pentraxin PTX3: a candidate anti-inflammatory mediator in cardiac surgery. |
| Q36600970 | Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome |
| Q37180338 | Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066) |
| Q36921904 | Transient expansion of activated CD8(+) T cells characterizes tuberculosis-associated immune reconstitution inflammatory syndrome in patients with HIV: a case control study. |
| Q36837809 | Tuberculosis-Associated Immune Reconstruction Inflammatory Syndrome (TB-IRIS) in HIV-Infected Patients: Report of Two Cases and the Literature Overview |
| Q28749315 | Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings |
| Q42256456 | Ulcerating type 1 lepra reaction mimicking lazarine leprosy: an unusual presentation of immune reconstitution inflammatory syndrome in an HIV-infected patient |
| Q37867506 | Unmasking Immune Reconstitution Inflammatory Syndrome (IRIS): A report of five cases and review of the literature. |
| Q61446755 | Unusual manifestation of disseminated herpes simplex virus type 2 infection associated with pharyngotonsilitis, esophagitis, and hemophagocytic lymphohisitocytosis without genital involvement |
| Q37621603 | Update on immune reconstitution inflammatory syndrome: progress and unanswered questions |
| Q38091715 | Urban legends series: oral manifestations of HIV infection |
| Q81741351 | [Infections of the central nervous system in the immuno-compromised] |
Search more.